Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Reversal in Pregnant Women with Magnesium Prophylaxis
NCT05558969Completed
- Sponsor
- Eskişehir Osmangazi University
- Start
- Sep 2022
- Primary completion
- May 2025
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Eskişehir Osmangazi University. Primary endpoint: Time from sugammadex injection to Train-of-four ratio 0.9 at 2 hours. Started Sep 2022; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT05558969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05558969.